marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2022
added 04-17-2023
Blonder Tongue Laboratories Balance Sheet 2011-2024 | BDR
Annual Balance Sheet Blonder Tongue Laboratories
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
4.58 M | 1.54 M | 753 K | 2.21 M | 5.29 M | 6.29 M | 5.59 M | 6.37 M | 4.93 M | 5.37 M | 6.23 M | 2.23 M |
Long Term Debt |
4.09 M | 993 K | 28 K | 47 K | 171 K | 3.72 M | 3.71 M | 110 K | 3.61 M | 3.89 M | 4.16 M | 2.82 M |
Long Term Debt Current |
569 K | 826 K | 28 K | 33 K | 3.08 M | 249 K | 228 K | 3.6 M | 286 K | 270 K | 277 K | 258 K |
Total Non Current Liabilities |
- | - | 4.36 M | 2.62 M | 171 K | 3.82 M | 3.85 M | 239 K | 3.7 M | 3.96 M | 4.19 M | 2.82 M |
Total Current Liabilities |
8.16 M | 6.06 M | 5.53 M | 8.37 M | 8.26 M | 3.94 M | 4.62 M | 8.62 M | 3.8 M | 3.66 M | 5.48 M | 1.85 M |
Total Liabilities |
13.9 M | 8.62 M | 9.89 M | 11 M | 8.43 M | 7.76 M | 8.47 M | 8.86 M | 7.51 M | 7.61 M | 9.68 M | 4.67 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-30.2 M | -27.3 M | - | -19.9 M | -19.2 M | -17.8 M | -17.2 M | -12.2 M | -4.1 M | -3.19 M | -372 K | 4.78 M |
Total Assets |
15 M | 11.9 M | 11.1 M | 18.3 M | 15.6 M | 15.2 M | 15 M | 16.2 M | 21.2 M | 22.6 M | 26.3 M | 25.9 M |
Cash and Cash Equivalents |
79 K | 274 K | 69 K | 572 K | 559 K | 168 K | 468 K | 9 K | 232 K | 67 K | 453 K | 851 K |
Book Value |
1.07 M | 3.28 M | 1.24 M | 7.36 M | 7.17 M | 7.41 M | 6.53 M | 7.37 M | 13.7 M | 15 M | 16.6 M | 21.2 M |
Total Shareholders Equity |
1.07 M | 3.28 M | 1.24 M | 7.36 M | 7.17 M | 7.41 M | 6.53 M | 7.37 M | 13.7 M | 15 M | 16.6 M | 21.2 M |
All numbers in USD currency
Quarterly Balance Sheet Blonder Tongue Laboratories
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 4.24 M | 549 K | - | 993 K | - | - | - | 1.8 M | - | - | 41 K | 47 K | 45 K | 24 K | 47 K | 32 K | 32 K | 32 K | 32 K | 3.09 M | 3.09 M | 3.09 M | 3.09 M | 3.34 M | 3.34 M | 3.34 M | 3.34 M | 10 K | 10 K | 10 K | 10 K | 3.61 M | 3.61 M | 3.61 M | 3.61 M | 3.89 M | 3.89 M | 3.89 M | 3.89 M | 4.16 M | 4.16 M | 4.16 M | 4.16 M | 2.82 M | 2.82 M | 2.82 M | 2.82 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 14.3 M | 10.8 M | 9.12 M | 8.62 M | 8.38 M | 8.42 M | 9.62 M | 9.89 M | 9.89 M | 9.89 M | 9.89 M | 11 M | 11 M | 11 M | 11 M | 8.43 M | 8.43 M | 8.43 M | 8.43 M | 7.76 M | 7.76 M | 7.76 M | 7.76 M | 8.47 M | 8.47 M | 8.47 M | 8.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | -30.3 M | -29.6 M | -28.5 M | -27.3 M | -26.4 M | -26.2 M | -27.8 M | -27.4 M | -27.4 M | -27.4 M | -27.4 M | -19.9 M | -19.9 M | -19.9 M | -19.9 M | -19.2 M | -19.2 M | -19.2 M | -19.2 M | -17.8 M | -17.8 M | -17.8 M | -17.8 M | -17.2 M | -17.2 M | -17.2 M | -17.2 M | -12.2 M | -12.2 M | -12.2 M | -12.2 M | -4.1 M | -4.1 M | -4.1 M | -4.1 M | -3.19 M | -3.19 M | -3.19 M | -3.19 M | -372 K | -372 K | -372 K | -372 K | 4.78 M | 4.78 M | 4.78 M | 4.78 M |
Total Assets |
- | 15.3 M | 12.3 M | 11.5 M | 11.9 M | 12.1 M | 11.9 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 15 M | 15 M | 15 M | 15 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M |
Cash and Cash Equivalents |
- | 167 K | 361 K | 110 K | 274 K | 271 K | 344 K | 56 K | 69 K | 69 K | 69 K | 69 K | 572 K | 572 K | 572 K | 572 K | 559 K | 559 K | 559 K | 559 K | 168 K | 168 K | 168 K | 168 K | 468 K | 468 K | 468 K | 468 K | 9 K | 9 K | 9 K | 9 K | 232 K | 232 K | 232 K | 232 K | 67 K | 67 K | 67 K | 67 K | 453 K | 453 K | 453 K | 453 K | 851 K | 851 K | 851 K | 851 K |
Book Value |
- | 937 K | 1.47 M | 2.41 M | 3.28 M | 3.76 M | 3.49 M | 1.5 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M | 7.36 M | 7.36 M | 7.36 M | 7.36 M | 7.17 M | 7.17 M | 7.17 M | 7.17 M | 7.41 M | 7.41 M | 7.41 M | 7.41 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 26.3 M | 26.3 M | 26.3 M | 26.3 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M |
Total Shareholders Equity |
- | 937 K | 1.47 M | 2.41 M | 3.28 M | 3.76 M | 3.49 M | 1.5 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M | 7.36 M | 7.36 M | 7.36 M | 7.36 M | 7.17 M | 7.17 M | 7.17 M | 7.17 M | 7.41 M | 7.41 M | 7.41 M | 7.41 M | 6.53 M | 6.53 M | 6.53 M | 6.53 M | 7.37 M | 7.37 M | 7.37 M | 7.37 M | 13.7 M | 13.7 M | 13.7 M | 13.7 M | 15 M | 15 M | 15 M | 15 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M |
All numbers in USD currency